Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11504394
Targeted ionophore-based metal delivery
granted patentUS 11505798
Methods and compositions for treating inflammatory diseases
granted patentUS 11505574
Modulation of P53 for the treatment of cancer
granted patentUS 11504427
Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy
granted patentUS 11505598
Antibodies to botulinum neurotoxins
granted patentUS 11498905
Inhibitors of platelet function and methods for use of the same
granted patentUS 11492406
Methods and compositions for treating and preventing disease associated with alpha-v beta-
granted patentUS 11484521
Antidotes to cyanide poisoning
granted patentUS 11484525
Mu opioid receptor modulators
granted patentUS 11485758
Bi-terminal pegylated integrin-binding peptides and methods of use thereof
granted patentUS 11485760
Inhibitors of CRISPR-Cas9
granted patentUS 11485961
Compositions and methods for treating celiac sprue disease
granted patentUS 11479601
Antibodies specific to Sonic Hedgehog and method of use thereof
granted patentUS 11478510
Chimeric antigen receptor and methods of use thereof
granted patentUS 11479775
RNA targeting of mutations via suppressor tRNAs and deaminases
granted patentUS 11478500
Anticancer compositions and methods for making and using them
granted patentUS 11478556
Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration
granted patentUS 11479794
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 11478568
Radioactive cement
granted patentUS 11479530
Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of tr
granted patentUS 11472804
Compositions and methods for modulating hair growth
granted patentUS 11472859
Method and composition for treating neuronal hyper-excitabtiity
granted patentUS 11473108
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 11464784
Inhibition of aminocylase 3 (AA3) in the treatment of cancer
granted